Bangladesh - English - DGDA (Directorate General of Drug Administration)

synovia pharma plc. - cetrimide + chlorhexidine gluconate - solution - 3 gm + 300 mg/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

synovia pharma plc. - cetrimide + chlorhexidine hydrochloride - cream - 500 mg + 100 mg/100 gm

United States - English - NLM (National Library of Medicine)

miskin co ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer to help reduce bacteria that potentially can cause disease for use when soap and water are not available place enough product on hands to cover all surfaces.rub hands together until dry. supervise children under 6 years of age when using this product to avoid swallowing.

United States - English - NLM (National Library of Medicine)

miskin co ltd - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer to help reduce bacteria that potentially can cause disease for use when soap and water are not available place enough product on hands to cover all surfaces.rub hands together until dry. supervise children under 6 years of age when using this product to avoid swallowing.

Israel - English - Ministry of Health

medison pharma ltd - setmelanotide - solution for injection - setmelanotide 10 mg / 1 ml - imcivree is indicated for the treatment of obesity and the control of hunger associated with genetically confirmed bardet-biedl syndrome (bbs), loss-of-function biallelic pro-opiomelanocortin (pomc), including pcsk1, deficiency or biallelic leptin receptor (lepr) deficiency in adults and children 6 years of age and above.

Israel - English - Ministry of Health

medison pharma ltd - tebentafusp - concentrate for solution for infusion - tebentafusp 0.2 mg/ml - tebentafusp - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Israel - English - Ministry of Health

medison pharma ltd - dextromethorphan hydrobromide; quinidine sulfate - capsules - quinidine sulfate 10 mg; dextromethorphan hydrobromide 20 mg - quinidine - quinidine - for the treatment of pseudobulbar affect (pba) .

Israel - English - Ministry of Health

medison pharma ltd - lanreotide acetate - powder and solvent for suspension for injection - lanreotide acetate 0.03 g/vial - lanreotide - lanreotide - treatment of acromegaly (when the treatment of growth hormone is not normalized after surgery and/or radiotherapy). treatment of the clinical symptoms of carcinoid tumors (after a test injection). treatment of primary thyrotropic adenomas responsible for hypethyroidism as a preparation for / or as a complement to surgery and/or radiotherapy or where these therapies are unsuitable.

Israel - English - Ministry of Health

medison pharma ltd - lanreotide as acetate - solution for injection - lanreotide as acetate 60 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.somatuline autogel is also indicated for the treatment of grade 1 and a subset of grade 2 (ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumors (gep-nets) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.

Israel - English - Ministry of Health

medison pharma ltd - lanreotide as acetate - solution for injection - lanreotide as acetate 90 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.somatuline autogel is also indicated for the treatment of grade 1 and a subset of grade 2 (ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumors (gep-nets) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.